TMED10: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD
It’s the GeneMedi’s summary page for Target/Biomarker Introduction of TMED10. The page also collects GeneMedi’s different modalities and formats products for TMED10 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the TMED10 target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Transmembrane Protein.
This gene is a member of the EMP24/GP25L/p24 family and encodes a protein with a GOLD domain. This type I membrane protein is localized to the plasma membrane and golgi cisternae and is involved in vesicular protein trafficking. The protein is also a member of a heteromeric secretase complex and regulates the complex’s gamma-secretase activity without affecting its epsilon-secretase activity. Mutations in this gene have been associated with early-onset familial Alzheimer’s disease. This gene has a pseudogene on chromosome 8. [provided by RefSeq, Jul 2008]
|
Target ID |
GM-MP1807
|
|
Target Name |
TMED10
|
|
Gene ID |
10972
|
|
Gene Official Name |
TMED10
|
|
Gene Alias |
P24(DELTA), S31I125, S31III125, TMP21, Tmp-21-I, p23, p24d1
|
|
Protein Sub-location |
Transmembrane Protein
|
|
Category |
|
Anti-TMEDA/ TMED10/ P24(DELTA) antibody for FACS & in-vivo assay| GMab
Pre-made anti-TMED10 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TMED10 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Warning: Undefined array key "category" in /www/wwwroot/genemedi_com0630/wp-content/plugins/wc-product-table-pro/pro/functions.php on line 2278
